Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Magnetic Resonance Imaging (MRI) Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 112 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 112 pages
- Published: 10-06-2019
Market Overview
The key factors propelling the growth of the global magnetic resonance imaging market are an increase in technological advancement, such as the inclusion of MRI with PET or CT, to provide imaging possibilities with less exposure to harmful radiations, rising adoption of MRI in developing countries, and availability with rising adoption of Universal health coverage in the developed and developing markets. The global players, such as GE, Siemens, and Philips, have an extensive hold on improving technology, as well as global distribution channels, which helps the increasing number of public and private diagnostic centers around the world. However, the use of refurbished MRI equipment is also widely preferred in the developing markets, due to its cost-effectiveness and easy availability.
The current market is experiencing major technological advancements. The limits of the largest field strength of electromagnets in MRI has expanded beyond the conventional 1.5T-3T to a staggering 7T. This leap in technology has widened the application profile of MRI devices and is expected to further expand in the forecast period.
The current global MRI market is plagued with issues of low reimbursement rates for MRI procedures and problems with post-sale service. MRIs are high-cost capital equipment with an average lifespan ranging between 7-14 years. As such, post-sales service becomes an important factor for purchasers, but the current market has been largely unsuccessful in addressing these needs.
Scope of the Report
Magnetic resonance imaging is a medical imaging technique, which is used in radiology to produce pictures of the anatomy and the physiological processes of the body in both health and disease. These pictures are further used to diagnose and detect the presence of abnormalities in the body.
Key Market Trends
Neurology Segment Holds the Largest Market Share Currently and is Believed to Continue the Same Over the Forecast period.
The neurology segment of the global MRI market holds the largest market share, and it is expected to record a CAGR of 6.7% in the coming future.
MRI is the best tool for diagnostic imaging and neuroscience research. It provides morphological images with the highest spatial resolution and unmatched soft tissue contrast, as well as the unique functional information of the central nervous system (CNS). 97% of MRI sites perform the brain examinations and 1 in 4 MRI scans is of the brain, making it one of the most commonly performed exams in neurology. Neurological uses of MRI systems include the diagnosis of brain and spinal cord tumors, infection and vascular irregularities, which may lead to stroke. MRI can also detect the disorders, along with performing the monitoring of degenerative disorders, such as multiple sclerosis, and it can even document brain injury from trauma.
North America Dominates the MRI Market and is Expected to Hold The Largest Market Share During the Forecast Period.
North America currently dominates the global magnetic resonance imaging market, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the well-established healthcare system of the United States and the initiatives that are being carried out by the various organizations, along with the government to promote the disease diagnosis. Siemens and Philips are the leading companies in the United States. The average MRI scanning cost ranges between USD 650 to USD 950 based on dye being used or not. With that, the United States has the largest market share of approximately 94.6% in North America, and is expected to record a CAGR of 6.3% over the forecast period.
Competitive Landscape
The global magnetic resonance imaging market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancement and quality service provision, mid-size to smaller companies are increasing their market presence by introducing new products with fewer prices. Companies, like Siemens Healthineers, GE Healthcare, Canon Medical Systems, and Philips Healthcare hold a significant market share in the global magnetic resonance imaging market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Introduction of Hybrid MRI Systems
4.2.2 Availability of Universal Health Coverage in North America, Europe and several Asian Countries
4.2.3 Increasing Adoption in Emerging Markets
4.3 Market Restraints
4.3.1 High Cost of MRI Systems
4.3.2 Declining Helium Availability
4.3.3 Capital Equipment Nature of MRI Systems
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Architecture
5.1.1 Closed MRI Systems
5.1.2 Open MRI Systems
5.2 Field Strength
5.2.1 Low Field MRI Systems
5.2.2 High Field MRI Systems
5.2.3 Very High Field MRI Systems and Ultra-high MRI Systems
5.3 Application
5.3.1 Oncology
5.3.2 Neurology
5.3.3 Cardiology
5.3.4 Gastroenterology
5.3.5 Musculoskeletal
5.3.6 Other Applications
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bruker Corporation
6.1.2 Esaote SpA
6.1.3 Fonar Corporation
6.1.4 GE Healthcare
6.1.5 Hitachi Ltd
6.1.6 Neusoft Medical Systems Co. Ltd
6.1.7 Koninklijke Philips NV
6.1.8 Siemens Healthcare GmbH
6.1.9 Aurora Imaging Technology
6.1.10 Canon Medical Systems Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Architecture
Closed MRI Systems
Open MRI Systems
Field Strength
Low Field MRI Systems
High Field MRI Systems
Very High Field MRI Systems and Ultra-high MRI Systems
Application
Oncology
Neurology
Cardiology
Gastroenterology
Musculoskeletal
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Laboratory Informatics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 116 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 116 pages
- Published: 07-06-2019
Market Overview
The global laboratory informatics market was valued at USD 2,395.69 million in 2018, and is estimated to be valued at USD 3,729.23 million in 2024, witnessing a CAGR of 7.65%. Factors that are driving the market include high accuracy and efficiency of results, increasing applications of lab informatics solutions, and increasing number of diagnoses.
Owing to the increased workload, cost constraints, and advancements in technologies, the nature of pathology is rapidly changing, as per the need of the market. New laboratory systems are manufactured with the best technologies to alleviate the current global demand. New approaches for managing laboratory information are now required to fulfill the changing requirements of the healthcare system. The primary concern for clinicians is the accuracy of the information that they get through various resources. However, it was stated by the World Health Organization that around 5% of the patients face diagnostic errors each year in the developed countries, and about 7% of the abnormal test results are not delivered to the patients. Thus, to avoid these diagnostic errors and to provide better services, clinics and laboratories are implementing various tools, such as laboratory information systems (LIS) and LIMS.
Scope of the Report
Laboratory informatics is the specialized application of information with the help of a platform consisting of equipment, software, and data management tools that allow scientific data to be captured, migrated, processed, and interpreted for immediate use, as well as for future use.
Key Market Trends
Laboratory Information Management System is Expected to hold its Highest Market Share in the Product
In the product segment of the laboratory informatics market, laboratory information management system is believed to have the largest market size and is expected to witness a CAGR of 7.18% during the forecast period.
LIMS are usually intended for the laboratories having recurring workflows, such as quality control laboratories. LIM system contains a special data structure, and the processes of the laboratory (workflow) should already be established in a certain format. LIMS products have been losing market share to electronic lab notebooks (ELN) and laboratory execution system (LES) in the recent years. This trend can be observed in the sales growth of LES vendors and in the investment of large LIMS providers in the field of ELN and LES. Some of the major players in the market studied, such as LabVantage Solutions Inc., have invested heavily, in order to develop comprehensive and highly integrated LES and ELN capabilities.
North America Domainates the Market and is Expected to do the Same in the Forecasted Period
North America currently dominates the market for laboratory informatics and is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the well-established healthcare industry and better reimbursement facilities in the region. The United States holds the majority of the market in the North American region, due to the higher adoption of digital healthcare in the country and the rising investments done by the companies over there.
Competitive Landscape
The laboratory informatics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. Companies, like Abbott Laboratories (Abbott Informatics Corporation), Agilent Technologies, McKesson Corporation, Thermo Fischer Scientific Inc., hold substantial shares in the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Accuracy and Efficiency of Results
4.2.2 Increasing Applications of Lab Informatics Solutions
4.2.3 Increasing Number of Diagnoses
4.3 Market Restraints
4.3.1 Lack of Integration Standards for Laboratory Informatics
4.3.2 Lack of Skilled Professionals
4.4 Industry Attractiveness – Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Laboratory Information Management System (LIMS)
5.1.2 Electronic Lab Notebooks (ELN)
5.1.3 Enterprise Content Management (ECM)
5.1.4 Laboratory Execution System (LES)
5.1.5 Chromatography Data System (CDS)
5.1.6 Scientific Data Management System (SDMS)
5.1.7 Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
5.2 By Component
5.2.1 Services
5.2.2 Software
5.3 By Delivery Mode
5.3.1 On-premise
5.3.2 Web-hosted
5.3.3 Cloud-based
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories (Abbott Informatics Corporation)
6.1.2 Agilent Technologies
6.1.3 Cerner Corporation
6.1.4 McKesson Corporation
6.1.5 Thermo Fisher Scientific Inc.
6.1.6 LabLynx Inc.
6.1.7 LabVantage Solutions Inc.
6.1.8 LabWare Inc.
6.1.9 PerkinElmer Inc.
6.1.10 Waters Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product
Laboratory Information Management System (LIMS)
Electronic Lab Notebooks (ELN)
Enterprise Content Management (ECM)
Laboratory Execution System (LES)
Chromatography Data System (CDS)
Scientific Data Management System (SDMS)
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
By Component
Services
Software
By Delivery Mode
On-premise
Web-hosted
Cloud-based
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Iron Deficiency Anemia Therapy Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
Iron deficiency anemia is a common condition affecting, especially, children and young women across the world. Iron deficiency is a major problem in developed countries, such as the United States, Canada, the United Kingdom, and across Europe. Moreover, in developing countries, iron deficiency anemia is frequently exacerbated by malaria and other worm infections. The current market is growing, due to the rising incidences of iron deficiency anemia. The increasing risk of hemodilution in pregnant women acts as a major driver for this market. The need to reduce the burden of iron-deficiency anemia has led to an increase in the demand for its treatment, which subsequently drives the global market.
Scope of the Report
This report estimates the global iron deficiency anemia therapy market. It includes a detailed analysis of the various available therapies for treating anemia in healthcare facilities of major geographical regions. Iron deficiency anemia is caused due to the lack of iron and is is one of the most common types of anemia. In case of women, during the child-bearing age, iron loss in the blood will be caused due to heavy menstruation or pregnancy. Certain intestinal diseases and poor diet can also cause anemia.
Key Market Trends
Parenteral Iron Therapy Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
Parenteral iron therapy is generally offered to patients who are either unable to absorb oral iron or are still diagnosed with increasing anemia, even after taking adequate doses of oral iron supplements. Many intravenous iron supplementation products are being approved by FDA, which is likely to drive the market in the future. Administration of parenteral iron supplement can lead to adverse effects, such as anaphylaxis, shock, severe hypotension, collapse, and loss of consciousness. Prevalence of anemia cases and patients’ irresponsiveness toward oral and dietary therapies are the factors likely to drive the market over the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America dominated the overall iron deficiency anemia therapy market, with the United States being the major contributor to the market. The prevalence of anemia is a significant public health indicator and has remained a relevant health concern in the United States. Since 1990, the prevalence rate of iron deficiency anemia in US infants did not drop, making iron deficiency a significant public health problem in the United States. Hence, the high prevalence rate of anemia is expected to boost the growth of the market in North America.
Competitive Landscape
High sustainable competitive advantage through innovation is also contributing to the increasing competitive rivalry. The presence of a significant number of players in the market studied has an impact on the prices of products by firms, such as Allergan, Integra Lifesciences, Galderma Pharma SA, Teoxane, and Sinclair Pharma PLC, among others. The industry is witnessing a series of acquisitions and mergers.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cases of Haemodilution in Pregnancy
4.2.2 High Prevalence of Anemia
4.3 Market Restraints
4.3.1 Stringent Regulatory Guidelines
4.3.2 Adverse Effects
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Therapy Type
5.1.1 Oral Iron Therapy
5.1.2 Parenteral Iron Therapy
5.1.3 Red Blood Cell Transfusion
5.1.4 Other Therapy Types
5.2 End User
5.2.1 Hospitals
5.2.2 Clinics
5.2.3 Home Healthcare
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergen
6.1.2 Akebia Therapeutics
6.1.3 AMAG Pharmaceuticals
6.1.4 Keryx Biopharmaceuticals Inc.
6.1.5 Luitpold Pharmaceuticals Inc.
6.1.6 Johnson & Johnson
6.1.7 Pharmacosmos AS
6.1.8 Pieris
6.1.9 Allergen
6.1.10 AMAG Pharmaceuticals
6.1.11 Johnson & Johnson
6.1.12 Pharmacosmos A/S
6.1.13 Pieris
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Therapy Type
Oral Iron Therapy
Parenteral Iron Therapy
Red Blood Cell Transfusion
Other Therapy Types
End User
Hospitals
Clinics
Home Healthcare
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Ion Chromatography Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 10-06-2019
Market Overview
The growth of the global ion chromatography market is due to the increasing use of ion-exchange chromatography for purification, along with the increasing demand for monoclonal antibodies, which is a primary driver for the market. The current market is also growing due to the increasing adoption of ion-exchange techniques in the food, beverage, and water industries. To check content, quality, or safety, ion chromatography is increasingly being used in various industries. The ion-exchange technique is also being used to check the presence or amount of ingredients in a sample. The high cost of chromatography instruments and the lack of skilled personnel to handle the equipment are hindering the growth of the ion chromatography market.
Scope of the Report
This report estimates the global ion chromatography market. It incorporates a detailed analysis of technology, which includes ion-exchange chromatography, ion-exclusion chromatography, and ion-pair chromatography. Ion chromatography is a well-established technique for the analysis of anions and cations in liquid, gaseous, and solid samples. Organizations, such as the ISO, US EPA, ASTM, and AOAC have established their standards on regulatory methods of analysis using this technique. Currently, electrochemical and spectrometric methods are the two detection methods applied in ion chromatography.
Key Market Trends
Ion-exchange Chromatography Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period
There are two types of ion-exchange chromatography techniques, based on the nature of charge present on the ion. They are anion exchange chromatography and cation exchange chromatography. Ion exchange resins are useful as carriers for medicinal materials and in slow release applications. Cholestyramine, a dried and ground strong base anion resin, is used in binding the bile acid for reducing blood cholesterol. The usage of this ion exchange in the medical field is increasing, and thus, driving the market growth.
One of the main advantages of ion exchange is that there is only one interaction involved in the separation, the analytical species interacting with the stationary phase; while the downside of ion-exchange chromatography is the high cost of these columns. The ion-exchange chromatography market share is dominant, due to a wide range of applications and associated markets. This market share is expected to increase further during the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
In the United States, ion chromatography is used for many applications. Ion chromatography (IC) has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, food testing, and other applications. The United States Pharmacopeia (USP) is a non-government not-for-profit organization that supports itself through the sale of books (USP-NF and other publications) and reference standards. USP sets standards for the use of ion chromatography in pharmaceutical applications. Many organizations, such as USEPA (United States Environmental Protection Agency), ASTM (American Society for Testing and Materials), and AOAC (Association of Official Analytical Chemists) are some of the additions to the market in the United States. These organizations also develop standards or regulatory methods of analysis for various applications of ion chromatography.
Competitive Landscape
Agilent Technologies, Bio-Rad Laboratories Inc., GE Healthcare, Metrohm AG, and Mitsubishi Chemical Corporation are some of the major players in the ion chromatography market that are disrupting the market by launching several new products.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Academic and Commercial R&D Spending on Pharmaceuticals
4.2.2 Increasing Use of Ion Chromatography Technique in Purifying Monoclonal Antibodies (MABS)
4.2.3 Increasing Use of Ion Chromatography Technique in the Food, Beverage, and Water Industries
4.2.4 Technological Advancements in Ion Chromatography
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.3.2 Lack of Skilled Personnel to Handle Equipment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Technology
5.1.1 Ion-exchange Chromatography
5.1.2 Ion-exclusion Chromatography
5.1.3 Ion-pair Chromatography
5.2 Application
5.2.1 Environmental Testing
5.2.2 Pharmaceutical Industry
5.2.3 Food Industry
5.2.4 Chemicals Industry
5.2.5 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Bio-Rad Laboratories Inc.
6.1.3 GE Healthcare
6.1.4 Metrohm AG
6.1.5 Mitsubishi Chemical Corporation
6.1.6 Perkin Elmer Inc.
6.1.7 Shimadzu Corporation
6.1.8 Thermo Fisher Scientific
6.1.9 Tosoh Corporation
6.1.10 Waters
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Technology
Ion-exchange Chromatography
Ion-exclusion Chromatography
Ion-pair Chromatography
Application
Environmental Testing
Pharmaceutical Industry
Food Industry
Chemicals Industry
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Insulin Infusion Pumps Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 100 pages | Published: 13-06-2019 |
- Healthcare
- Mordor Intelligence
- 100 pages
- Published: 13-06-2019
Market Overview
The global insulin infusion pump market is set to witness a CAGR of 7.51% during the forecast period. Insulin infusion pumps work as an alternative to the traditional system of daily injections or an insulin pen.
Insulin infusion pumps reduce the large swings in blood glucose level, lessen pain, and deliver more accurately than injections. The scheduling of meal timings is not required when using pumps.
This makes infusion pumps more user-friendly for patients. Insulin therapy is also known as continuous subcutaneous insulin infusion (CSII). It is an efficient and flexible method of insulin delivery.
The insulin pump has evolved and is more reliable than it was previously. CSII technology has witnessed numerous technological advancements, like the integration of continuous glucose monitoring with the pump. Now, insulin pumps can control the algorithm that automatically delivers the insulin, after analyzing the blood glucose reading
Scope of the Report
The insulin market is segmented into the device, infusion set, and reservoir. The report is also segmented into five regions: North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America.
Key Market Trends
The Insulin Pump Market is Growing with the CAGR of 7% in the Forecast Period
Owing to the rising rate of obesity, growing genetic factors for type 2 diabetes, and the increasing number of type 1 diabetes patients, it is likely that the insulin infusion pump market will continue to grow.
Insulin pump use is high among the type 1 population. It is also growing in type 2 patients. The ratio of children to adult, or type 1 to type 2, patient’s usage of insulin pumps varies across countries.
North America Holds the Highest Market Share
North America holds the highest market share in the insulin pump market and is also expected to grow with the highest CAGR, of 9.05% in the forecast period, because of the favorable reimbursement policy. Although the pump and its supplies (tubing, insulin cartridges, and infusion sets) continue to be expensive, insurance coverage has improved considerably over the years.
Competitive Landscape
Animas had to exit the insulin pump market, as the company has admitted that rising competition was the reason for them to leave the market.
Medtronic is the market leader and is expected to maintain its position during the forecast period.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product (Value and Volume 2012-2024)
5.1.1 Insulin Pumps
5.1.2 Infusion Sets
5.1.3 Reservoirs
5.2 Geography
5.2.1 North America
5.2.1.1 United States (Value and Volume 2012-2024)
5.2.1.1.1 By Insulin Pump Devices
5.2.1.1.2 By Infusion Sets
5.2.1.1.3 By Reservoirs
5.2.1.2 Canada (Value and Volume 2012-2024)
5.2.1.2.1 By Insulin Pump Devices
5.2.1.2.2 By Infusion Sets
5.2.1.2.3 By Reservoirs
5.2.1.3 Rest of North America (Value and Volume 2012-2024)
5.2.1.3.1 By Insulin Pump Devices
5.2.1.3.2 By Infusion Sets
5.2.1.3.3 By Reservoirs
5.2.2 Asia-Pacific
5.2.2.1 Japan (Value and Volume 2012-2024)
5.2.2.1.1 By Insulin Pump Devices
5.2.2.1.2 By Infusion Sets
5.2.2.1.3 By Reservoirs
5.2.2.2 South Korea (Value and Volume 2012-2024)
5.2.2.2.1 By Insulin Pump Devices
5.2.2.2.2 By Infusion Sets
5.2.2.2.3 By Reservoirs
5.2.2.3 China (Value and Volume 2012-2024)
5.2.2.3.1 By Insulin Pump Devices
5.2.2.3.2 By Infusion Sets
5.2.2.3.3 By Reservoirs
5.2.2.4 India (Value and Volume 2012-2024)
5.2.2.4.1 By Insulin Pump Devices
5.2.2.4.2 By Infusion Sets
5.2.2.4.3 By Reservoirs
5.2.2.5 Australia (Value and Volume 2012-2024)
5.2.2.5.1 By Insulin Pump Devices
5.2.2.5.2 By Infusion Sets
5.2.2.5.3 By Reservoirs
5.2.2.6 Vietnam (Value and Volume 2012-2024)
5.2.2.6.1 By Insulin Pump Devices
5.2.2.6.2 By Infusion Sets
5.2.2.6.3 By Reservoirs
5.2.2.7 Malaysia (Value and Volume 2012-2024)
5.2.2.7.1 By Insulin Pump Devices
5.2.2.7.2 By Infusion Sets
5.2.2.7.3 By Reservoirs
5.2.2.8 Indonesia (Value and Volume 2012-2024)
5.2.2.8.1 By Insulin Pump Devices
5.2.2.8.2 By Infusion Sets
5.2.2.8.3 By Reservoirs
5.2.2.9 Philippines (Value and Volume 2012-2024)
5.2.2.9.1 By Insulin Pump Devices
5.2.2.9.2 By Infusion Sets
5.2.2.9.3 By Reservoirs
5.2.2.10 Thailand (Value and Volume 2012-2024)
5.2.2.10.1 By Insulin Pump Devices
5.2.2.10.2 By Infusion Sets
5.2.2.10.3 By Reservoirs
5.2.2.11 Rest of Asia-Pacific (Value and Volume 2012-2024)
5.2.2.11.1 By Insulin Pump Devices
5.2.2.11.2 By Infusion Sets
5.2.2.11.3 By Reservoirs
5.2.3 Europe
5.2.3.1 United Kingdom (Value and Volume 2012-2024)
5.2.3.1.1 By Insulin Pump Devices
5.2.3.1.2 By Infusion Sets
5.2.3.1.3 By Reservoirs
5.2.3.2 France (Value and Volume 2012-2024)
5.2.3.2.1 By Insulin Pump Devices
5.2.3.2.2 By Infusion Sets
5.2.3.2.3 By Reservoirs
5.2.3.3 Germany (Value and Volume 2012-2024)
5.2.3.3.1 By Insulin Pump Devices
5.2.3.3.2 By Infusion Sets
5.2.3.3.3 By Reservoirs
5.2.3.4 Italy (Value and Volume 2012-2024)
5.2.3.4.1 By Insulin Pump Devices
5.2.3.4.2 By Infusion Sets
5.2.3.4.3 By Reservoirs
5.2.3.5 Spain (Value and Volume 2012-2024)
5.2.3.5.1 By Insulin Pump Devices
5.2.3.5.2 By Infusion Sets
5.2.3.5.3 By Reservoirs
5.2.3.6 Russia (Value and Volume 2012-2024)
5.2.3.6.1 By Insulin Pump Devices
5.2.3.6.2 By Infusion Sets
5.2.3.6.3 By Reservoirs
5.2.3.7 Rest of Europe (Value and Volume 2012-2024)
5.2.3.7.1 By Insulin Pump Devices
5.2.3.7.2 By Infusion Sets
5.2.3.7.3 By Reservoirs
5.2.4 Latin America
5.2.4.1 Mexico (Value and Volume 2012-2024)
5.2.4.1.1 By Insulin Pump Devices
5.2.4.1.2 By Infusion Sets
5.2.4.1.3 By Reservoirs
5.2.4.2 Brazil (Value and Volume 2012-2024)
5.2.4.2.1 By Insulin Pump Devices
5.2.4.2.2 By Infusion Sets
5.2.4.2.3 By Reservoirs
5.2.4.3 Rest of Latin America (Value and Volume 2012-2024)
5.2.4.3.1 By Insulin Pump Devices
5.2.4.3.2 By Infusion Sets
5.2.4.3.3 By Reservoirs
5.2.5 Middle East & Africa
5.2.5.1 Saudi Arabia (Value and Volume 2012-2024)
5.2.5.1.1 By Insulin Pump Devices
5.2.5.1.2 By Infusion Sets
5.2.5.1.3 By Reservoirs
5.2.5.2 Iran (Value and Volume 2012-2024)
5.2.5.2.1 By Insulin Pump Devices
5.2.5.2.2 By Infusion Sets
5.2.5.2.3 By Reservoirs
5.2.5.3 Egypt (Value and Volume 2012-2024)
5.2.5.3.1 By Insulin Pump Devices
5.2.5.3.2 By Infusion Sets
5.2.5.3.3 By Reservoirs
5.2.5.4 Oman (Value and Volume 2012-2024)
5.2.5.4.1 By Insulin Pump Devices
5.2.5.4.2 By Infusion Sets
5.2.5.4.3 By Reservoirs
5.2.5.5 South Africa (Value and Volume 2012-2024)
5.2.5.5.1 By Insulin Pump Devices
5.2.5.5.2 By Infusion Sets
5.2.5.5.3 By Reservoirs
5.2.5.6 Rest of Middle East & Africa (Value and Volume 2012-2024)
5.2.5.6.1 By Insulin Pump Devices
5.2.5.6.2 By Infusion Sets
5.2.5.6.3 By Reservoirs
6 MARKET INDICATORS
6.1 Type-1 Diabetes Population (2012-2024)
6.2 Type-2 Diabetes Population (2012-2024)
7 COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Medtronic
7.1.2 Insulet
7.1.3 Roche
7.1.4 Animas
7.1.5 Tandem
7.1.6 Ypsomed
7.1.7 Cellnovo
7.2 COMPANY SHARE ANALYSIS
7.2.1 Roche
7.2.2 Animas
7.2.3 Medtronic
7.2.4 Others
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product (Value and Volume 2012-2024)
Insulin Pumps
Infusion Sets
Reservoirs
Geography
North America
United States (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Canada (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of North America (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Asia-Pacific
Japan (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Korea (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
China (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
India (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Australia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Vietnam (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Malaysia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Indonesia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Philippines (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Thailand (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Asia-Pacific (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Europe
United Kingdom (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
France (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Germany (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Italy (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Spain (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Russia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Europe (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Latin America
Mexico (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Brazil (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Latin America (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Middle East & Africa
Saudi Arabia (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Iran (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Egypt (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Oman (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
South Africa (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Rest of Middle East & Africa (Value and Volume 2012-2024)
By Insulin Pump Devices
By Infusion Sets
By Reservoirs
Influenza Diagnostics Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The global influenza diagnostics market was valued at USD 492.42 million in 2018, and is estimated to be valued at USD 731.97 million in 2024, witnessing a CAGR of 6.83%. Certain factors that are driving the market growth include increasing prevalence of influenza and related chronic diseases, growth in research funding for influenza diagnostics, and rising demand for early diagnosis and control of influenza.
Influenza is recognized as a crucial cause of morbidity and mortality in the human population, which is leading to the development and use of diagnostics that are intended for reducing consequent health and economic impacts. According to WHO, in 2018, influenza caused severe sickness or death mainly in patients at a high risk and illness range from mild to severe and even death. Also, this annual increase is projected to result in about 3-5 million cases of severe illness, and about 290,000-650,000 deaths, globally.
Various initiatives and research funding are bolstering the growth of the market. For instance, National Institute of Allergy and Infectious Disease (NIAID) has supported a broad portfolio of the influenza research, which includes studies that are informing the development of vaccines, diagnostics, and therapeutics against seasonal and pandemic influenza. Similarly, in 2018, a non-profit association between academic, government, and industry medical researchers, called Human Vaccine Project, launched the Universal Influenza Vaccine Initiative. Thus, growth in research funding by the government and companies for influenza diagnostics is driving the market.
However, it is critical to ensure that all the rapid antigen flu tests meet new FDA requirements for approval. Hence, the stringent FDA regulations act as significant restraints for the market.
Scope of the Report
Influenza, also known as flu, is a highly contagious infectious disease caused by a virus. This is an infection of the respiratory passages, which causes fever and severe aches. The influenza diagnostic market includes the tests that are conducted for the diagnosis of influenza cases. As per the scope of this report, only the test kits and reagents that are being used for the diagnosis of influenza have been taken into account for the calculation of the total market size.
Key Market Trends
Rapid Influenza Diagnostic Test (RIDT) is Expected to hold its Highest Market Share in the Test Type Segment
In the test type segment of the influenza diagnostics market, among all traditional diagnostic tests, the rapid influenza diagnostic test (RIDT) is believed to have the largest market size and is expected to witness a CAGR of 6.87% during the forecast period.
Rapid influenza diagnostic tests (RIDTs) are immunoassays, which help to identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens and qualitatively provide the results. It can diagnose patients, who are present with influenza-like illness, mainly if it is performed within the first four days of the onset of symptoms.
The rising popularity of RIDT is due to the benefits of faster result and simple usage. Some of the RIDTs are also approved for office/bedside use as well. The RIDT segment is also expected to witness rapid growth, as a result of their common usage in point-of-care settings.
However, one of the major drawback associated with RIDT is that it gives false negative results, due to its low to moderate sensitivities (50-70%). Healthcare policymakers began to recognize the impact of its low sensitivity in 2009, when the novel H1N1 influenza epidemic occurred.
North America Dominates the Market and is Expected to do the Same in the Forecast Period
North America currently dominates the market for influenza diagnostics and is expected to continue its stronghold for a few more years.
As per data published by the Centers for Disease Control and Prevention (CDC), RIDTs are commonly available across the region. The reason behind the wide availability of the test is the reduced time span needed to generate results. RIDT can yield results in 15 minutes. With increasing influenza-associated hospitalization and pediatric deaths and the interest of government organizations to better manage the disease, the North American influenza diagnostics market is expected to grow in the future.
Competitive Landscape
The influenza diagnostics market is highly competitive and consists of a few major players. In terms of market share, few of the major players currently dominate the market. Companies, like Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche AG, Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, and Sekisui Diagnostics., among others, hold the substantial share in the market.
Various developments have recently been taking place in the market; for instance, in March 2018, Sekisui Diagnostics launched the Silaris Influenza A and B test, developed in collaboration with Mesa Biotech. Also, in October 2017, Abbott Laboratories acquired Alere Inc. (Alere), a diagnostic device and service provider, which strengthened the company’s diagnostics presence.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Influenza and Related Chronic Diseases
4.2.2 Growth in Research Funding for Influenza Diagnostics
4.2.3 Rising Demand for Early Diagnosis and Control of Influenza
4.3 Market Restraints
4.3.1 Product Safety and High Cost of Development
4.3.2 Stringent Government Regulations
4.3.3 Variability in Sensitivity and Specificity among Influenza Diagnostic Tests
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Test Type
5.1.1 Traditional Diagnostic Test
5.1.1.1 Rapid Influenza Diagnostic Test (RIDT)
5.1.1.2 Viral Culture
5.1.1.3 Direct Fluorescent Antibody (DFA) Test
5.1.1.4 Serological Assay
5.1.2 Molecular Diagnostic Assay
5.1.2.1 RT-PCR
5.1.2.2 Nucleic Acid Sequence-based Amplification (NASBA) Test
5.1.2.3 Loop-mediated Isothermal Amplification-based Assay (LAMP)
5.1.2.4 Simple Amplification-based Assay (SAMBA)
5.1.2.5 Other Molecular Diagnostic Assays
5.2 End User
5.2.1 Hospital
5.2.2 Research Laboratory
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott
6.1.2 Becton, Dickinson and Company
6.1.3 Coris BioConcept
6.1.4 DiaSorin SpA
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Luminex Corporation
6.1.7 Meridian Bioscience Inc.
6.1.8 Quidel Corporation
6.1.9 Sekisui Diagnostics
6.1.10 Thermo Fisher Scientific Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Test Type
Traditional Diagnostic Test
Rapid Influenza Diagnostic Test (RIDT)
Viral Culture
Direct Fluorescent Antibody (DFA) Test
Serological Assay
Molecular Diagnostic Assay
RT-PCR
Nucleic Acid Sequence-based Amplification (NASBA) Test
Loop-mediated Isothermal Amplification-based Assay (LAMP)
Simple Amplification-based Assay (SAMBA)
Other Molecular Diagnostic Assays
End User
Hospital
Research Laboratory
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America